Qualification
MD - General Medicine, DM - Clinical Haematology, MBBSLanguages
English Hindi Kannada TeluguWork Experience
17 YearsResearch Experience
Research HighlightsDr. Nataraj K S is a prolific researcher in the field of hematology-oncology
having authored numerous peer-reviewed publications and presented his findings at international conferences. His research interests encompass a wide range of topics
including:
• Novel treatment strategies for hematological malignancies: Dr. Nataraj has actively investigated novel treatment approaches for various hematological malignancies
including leukemias
lymphomas
and myeloma. His research has focused on evaluating the efficacy and safety of new chemotherapy agents
targeted therapies
and immunotherapies.
• Optimizing blood and bone marrow transplantation: Dr. Nataraj has conducted extensive research on improving the outcomes of blood and bone marrow transplantation. His work has focused on refining patient selection criteria
developing more effective conditioning regimens
and strategies for preventing and managing graft-versus-host disease (GVHD).
• Genomics and personalized medicine in hematology-oncology: Dr. Nataraj is passionate about incorporating genomics and personalized medicine into hematology-oncology care. He has explored the role of genetic testing in guiding treatment decisions and tailoring therapy to the individual patient's genetic profile.
• Improving supportive care for hematology-oncology patients: Dr. Nataraj recognizes the importance of supportive care for patients with hematological malignancies and blood disorders. His research has focused on improving pain management
preventing and managing infections
and addressing psychosocial issues faced by these patients.
Research Publications and Presentations
Dr. Nataraj's research has been published in numerous peer-reviewed journals
including the Journal of Clinical Oncology
Blood
and the Leukemia journal. He has also presented his research findings at international conferences
including the Annual Meeting of the American Society of Hematology (ASH) and the European Hematology Association (EHA) congress.
Awards & Achivements
Dr. Nataraj K S's exceptional contributions to the field of hematology-oncology have been recognized through numerous prestigious awards and honors:• Annual Research Award from the Indian Society of Medical Oncology (ISMCO)
• Best Paper Award at the Annual Conference of the Indian Society of Hematology and Blood Transfusion (ISHBT)
• Lifetime Achievement Award from the Karnataka Chapter of Indian Society of Medical Oncology (ISMCO-Karnataka)
Memberships
• Indian Society of Medical Oncology (ISMCO)• American Society of Hematology (ASH)
• European Society for Medical Oncology (ESMO)
• Karnataka Chapter of Indian Society of Medical Oncology (ISMCO-Karnataka)
Area of Interest
• Hematological malignancies: Managing a broad spectrum of hematological malignanciesincluding leukemia
lymphomas
myeloma
and other blood cancers
using a comprehensive approach that combines chemotherapy
immunotherapy
and targeted therapy.
• Bloo